These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

449 related items for PubMed ID: 11149950

  • 1. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes.
    Laffitte BA, Repa JJ, Joseph SB, Wilpitz DC, Kast HR, Mangelsdorf DJ, Tontonoz P.
    Proc Natl Acad Sci U S A; 2001 Jan 16; 98(2):507-12. PubMed ID: 11149950
    [Abstract] [Full Text] [Related]

  • 2. Tissue-specific autoregulation of the LXRalpha gene facilitates induction of apoE in mouse adipose tissue.
    Ulven SM, Dalen KT, Gustafsson JA, Nebb HI.
    J Lipid Res; 2004 Nov 16; 45(11):2052-62. PubMed ID: 15292368
    [Abstract] [Full Text] [Related]

  • 3. The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesions.
    Laffitte BA, Joseph SB, Chen M, Castrillo A, Repa J, Wilpitz D, Mangelsdorf D, Tontonoz P.
    Mol Cell Biol; 2003 Mar 16; 23(6):2182-91. PubMed ID: 12612088
    [Abstract] [Full Text] [Related]

  • 4. A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes.
    Liang Y, Lin S, Beyer TP, Zhang Y, Wu X, Bales KR, DeMattos RB, May PC, Li SD, Jiang XC, Eacho PI, Cao G, Paul SM.
    J Neurochem; 2004 Feb 16; 88(3):623-34. PubMed ID: 14720212
    [Abstract] [Full Text] [Related]

  • 5. Induction of human liver X receptor alpha gene expression via an autoregulatory loop mechanism.
    Li Y, Bolten C, Bhat BG, Woodring-Dietz J, Li S, Prayaga SK, Xia C, Lala DS.
    Mol Endocrinol; 2002 Mar 16; 16(3):506-14. PubMed ID: 11875109
    [Abstract] [Full Text] [Related]

  • 6. Liver X receptor agonist methyl-3β-hydroxy-5α,6α-epoxycholanate attenuates atherosclerosis in apolipoprotein E knockout mice without increasing plasma triglyceride.
    Yan W, Zhang T, Cheng J, Zhou X, Qu X, Hu H.
    Pharmacology; 2010 Mar 16; 86(5-6):306-12. PubMed ID: 21071998
    [Abstract] [Full Text] [Related]

  • 7. LXR/RXR activation enhances basolateral efflux of cholesterol in CaCo-2 cells.
    Murthy S, Born E, Mathur SN, Field FJ.
    J Lipid Res; 2002 Jul 16; 43(7):1054-64. PubMed ID: 12091489
    [Abstract] [Full Text] [Related]

  • 8. The effect of T0901317 on ATP-binding cassette transporter A1 and Niemann-Pick type C1 in apoE-/- mice.
    Dai XY, Ou X, Hao XR, Cao DL, Tang YL, Hu YW, Li XX, Tang CK.
    J Cardiovasc Pharmacol; 2008 May 16; 51(5):467-75. PubMed ID: 18437096
    [Abstract] [Full Text] [Related]

  • 9. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling.
    Ide T, Shimano H, Yoshikawa T, Yahagi N, Amemiya-Kudo M, Matsuzaka T, Nakakuki M, Yatoh S, Iizuka Y, Tomita S, Ohashi K, Takahashi A, Sone H, Gotoda T, Osuga J, Ishibashi S, Yamada N.
    Mol Endocrinol; 2003 Jul 16; 17(7):1255-67. PubMed ID: 12730332
    [Abstract] [Full Text] [Related]

  • 10. Genetic deletion of low density lipoprotein receptor impairs sterol-induced mouse macrophage ABCA1 expression. A new SREBP1-dependent mechanism.
    Zhou X, He W, Huang Z, Gotto AM, Hajjar DP, Han J.
    J Biol Chem; 2008 Jan 25; 283(4):2129-38. PubMed ID: 18029360
    [Abstract] [Full Text] [Related]

  • 11. Role of p160 coactivator complex in the activation of liver X receptor.
    Huuskonen J, Fielding PE, Fielding CJ.
    Arterioscler Thromb Vasc Biol; 2004 Apr 25; 24(4):703-8. PubMed ID: 14764426
    [Abstract] [Full Text] [Related]

  • 12. Ligand, receptor, and cell type-dependent regulation of ABCA1 and ABCG1 mRNA in prostate cancer epithelial cells.
    Trasino SE, Kim YS, Wang TT.
    Mol Cancer Ther; 2009 Jul 25; 8(7):1934-45. PubMed ID: 19531574
    [Abstract] [Full Text] [Related]

  • 13. Autoregulation of the human liver X receptor alpha promoter.
    Laffitte BA, Joseph SB, Walczak R, Pei L, Wilpitz DC, Collins JL, Tontonoz P.
    Mol Cell Biol; 2001 Nov 25; 21(22):7558-68. PubMed ID: 11604492
    [Abstract] [Full Text] [Related]

  • 14. Cultured gallbladder epithelial cells synthesize apolipoproteins A-I and E.
    Lee J, Tauscher A, Seo DW, Oram JF, Kuver R.
    Am J Physiol Gastrointest Liver Physiol; 2003 Sep 25; 285(3):G630-41. PubMed ID: 12773300
    [Abstract] [Full Text] [Related]

  • 15. Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta.
    Repa JJ, Berge KE, Pomajzl C, Richardson JA, Hobbs H, Mangelsdorf DJ.
    J Biol Chem; 2002 May 24; 277(21):18793-800. PubMed ID: 11901146
    [Abstract] [Full Text] [Related]

  • 16. Characterization of ASC-2 as an antiatherogenic transcriptional coactivator of liver X receptors in macrophages.
    Kim GH, Park K, Yeom SY, Lee KJ, Kim G, Ko J, Rhee DK, Kim YH, Lee HK, Kim HW, Oh GT, Lee KU, Lee JW, Kim SW.
    Mol Endocrinol; 2009 Jul 24; 23(7):966-74. PubMed ID: 19342446
    [Abstract] [Full Text] [Related]

  • 17. The human ABCG1 gene: identification of LXR response elements that modulate expression in macrophages and liver.
    Sabol SL, Brewer HB, Santamarina-Fojo S.
    J Lipid Res; 2005 Oct 24; 46(10):2151-67. PubMed ID: 16024918
    [Abstract] [Full Text] [Related]

  • 18. T-0901317, a synthetic liver X receptor ligand, inhibits development of atherosclerosis in LDL receptor-deficient mice.
    Terasaka N, Hiroshima A, Koieyama T, Ubukata N, Morikawa Y, Nakai D, Inaba T.
    FEBS Lett; 2003 Feb 11; 536(1-3):6-11. PubMed ID: 12586329
    [Abstract] [Full Text] [Related]

  • 19. The RXR agonists PA024 and HX630 have different abilities to activate LXR/RXR and to induce ABCA1 expression in macrophage cell lines.
    Nishimaki-Mogami T, Tamehiro N, Sato Y, Okuhira K, Sai K, Kagechika H, Shudo K, Abe-Dohmae S, Yokoyama S, Ohno Y, Inoue K, Sawada J.
    Biochem Pharmacol; 2008 Oct 15; 76(8):1006-13. PubMed ID: 18761326
    [Abstract] [Full Text] [Related]

  • 20. LXR agonist suppresses atherosclerotic lesion growth and promotes lesion regression in apoE*3Leiden mice: time course and mechanisms.
    Verschuren L, de Vries-van der Weij J, Zadelaar S, Kleemann R, Kooistra T.
    J Lipid Res; 2009 Feb 15; 50(2):301-11. PubMed ID: 18757914
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.